Medical device briefs
Thursday, 05 February, 2009
Nanosonics has been granted approval by the Therapeutic Goods Administration to market its Trophon EPR device.
The device disinfects ultrasound probes and is aimed at hospitals, specialists and radiology clinics.
It has received earlier approval in the EU, Canada and New Zealand and is awaiting approval from the US FDA.
Polartechnics has signed agreements in Thailand, the Philippines, Indonesia and Sri Lanka for its TruScreen and CerviScreen diagnostics.
TruScreen is a point-of-care test for HPV while CerviScreen is a self-administered test.
Listed lab consumables company Fluorotechnics has changed its trading name to Gel Company. Its ASX name will remain the same.
mRNA therapy found to prevent recurrence of melanoma
Merck and Moderna have announced positive topline results from their Phase 3 trial of a...
A high-performance method for CRISPR off-target nomination
A new study provides evidence that can help gene editing developers prioritise biologically...
High doses of fertility drug linked to pregnancy risks
High doses of clomiphene citrate, accumulated over multiple fertility treatment cycles, could...
